The China API market is estimated to witness a growth rate of around 7.5% during the forecast period. China was the largest exporter of API globally with exporting volume of over 500 million tons in 2018. Well-developed infrastructure, large production capability, high prevalence of the chronic disease in the country such as cancer, CVD and so on are some of the factors that are responsible for the strong market growth in the country. China is the largest API supplier across the globe due to the increased focus on the pharmaceutical manufacturing sector coupled with the low production cost in the country.
Request a Free Sample of our China API Market: https://www.omrglobal.com/request-sample/china-api-market
The China API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the country’s API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others.
A full Report of China API Market is Available at: https://www.omrglobal.com/industry-reports/china-api-market
China API Market Segmentation
By Type
• General API
• Branded API
By Type of Synthesis
• Biotech API
• Synthetic API
• Others (High Potency API)
• China API Market by Therapeutics
• Cardiovascular Drugs
• Oncology Drugs
• Neurology Drugs
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Others (Orthopedic Drugs)
Company Profiles
• AbbVie Inc.
• Aesica Pharmaceuticals, Ltd.
• Almac group PLC
• Aurobindo Pharma
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline PLC
• Novartis International AG
• Piramal Enterprises Ltd.
• Sanofi SA
• Siegfried Holding AG
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Zhejiang Hisun Pharmaceutical Co., Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-api-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +1 646-755-7667, +91 7803040404